Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 20 of 123)
- Relevance
  Sort by

Antibiotics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Nephroblastoma Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
83 Pages
Global

From

€3500EUR$4,096USD£3,079GBP

Peptide Antibiotics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Glycopeptide Antibiotics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Kidney Cancer Treatment Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
98 Pages
Global

From

€3500EUR$4,096USD£3,079GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Non-Melanoma Skin Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
201 Pages
Global

€4572EUR$4,995USD£3,886GBP

Liver Cancer Therapeutics Market Analysis & Forecast 2024-2034: Market By Type; By Therapy; By Route of Administration; By Distribution Channel; and By Region

 Report
October 2023
145 Pages
Global

From

€2884EUR$3,150USD£2,451GBP

Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
207 Pages
Global

From

€1831EUR$2,000USD£1,556GBP

Diabetes Drug Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

 Report
March 2025
200 Pages
Global

From

€2279EUR$2,490USD£1,937GBP

Europe Colorectal Cancer Market to 2027 - Regional Analysis and Forecasts by Modality; End User, and Country

 Report
September 2022
181 Pages
Europe

From

€3158EUR$3,450USD£2,684GBP

Adult Malignant Glioma Therapeutics Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4530EUR$4,949USD£3,850GBP

Organ Transplant Immunosuppressant Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Non-Small Cell Lung Cancer Treatment Market Report and Forecast 2023-2031

 Report
April 2023
160 Pages
Global

From

€4530EUR$4,949USD£3,850GBP

Global Cell Therapy Biomanufacturing Market 2024-2029

 Report
August 2024
112 Pages
Global

From

€4257EUR$4,650USD£3,618GBP

Metastatic Melanoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
June 2022
946 Pages
Global

From

€2289EUR$2,500USD£1,945GBP

Opioid Use Disorder Drugs Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

 Report
April 2025
183 Pages
Global

From

€4119EUR$4,500USD£3,501GBP

Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030

 Report
November 2024
600 Pages
Global

From

€3021EUR$3,300USD£2,567GBP

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Drug Class, By Tumor Type, By Distribution Channel, By Region

 Report
November 2022
117 Pages
Global

From

€4119EUR$4,500USD£3,501GBP

Colorectal Cancer Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality and End-user

 Report
June 2022
259 Pages
Global

From

€4074EUR$4,450USD£3,462GBP

Cytotoxic Drugs and HPAPI Manufacturing Market by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of Highly Potent Finished Dosage Form, and Key Geographies, Europe, Asia-Pacific and Rest of the World: Industry Trends and Global Forecasts, 2022-2035

 Report
October 2022
338 Pages
Asia Pacific, Global, ... Asia Pacific, Global, Europe

From

€4393EUR$4,799USD£3,734GBP

2,452 Results (Page 20 of 123)
- 1
- 18
- 19
- 20
- 21
- 22

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.